Ginkgo plans a $17.5 billion merger with SPAC that took DraftKings public
Ginkgo plans a $17.5 billion merger with SPAC that took DraftKings public Jonathan Saltzman © Scott Eisen Jason Kelly, cofounder and chief executive of Ginkgo Bioworks. Ginkgo Bioworks, one of the hottest biotech startups in Massachusetts, said Tuesday that it plans to go public through a $17.5 billion merger with a so-called blank check company backed by Harry Sloan and Jeff Sagansky, the veteran media industry executives who helped take the Boston sports-betting company Dra...
United States United Kingdom Marine Industrial Park Massachusetts Institute Of Technology Jeff Sagansky Raymondl Flynn
Source: msn.com